Rocket Stocks For The Week of November 3-November 7
7227 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
Created by RocketStocks
DESCRIPTION:

Date updated:11-14-2008

The goal of this portfolio is not necessarily to find the best stocks for the next century but the ones that can either snapback this week because of an irrational selloff last week, or they have some other potential catalyst that can create explosive potential during the coming week

symbol name last price % change open
  • +
  • ENZN
    Enzon Pharmaceuti
  • $10.32
  • -0.67%
  • $10.51

Enzon Pharmaceuticals (ENZN): A bio-tech company, which has fallen from a high of $10 per share, to a current share-price of $5 per share. There are two activist investors in the company: Carl Icahn and DellaCamera Capital, both of who are pushing the company to sell parts of Enzon. In fact, in a recent letter to management, DellaCamera said “At the Company’s recent stock price of $6.42 per share, Enzon’s equity market capitalization is approximately $290 million. As you may recall, we have previously calculated Enzon’s remaining 75% stake in its PEG-Intron royalty stream to be worth $300 million alone! In addition, the Company had over $190 million of cash and marketable securities as of June 30, 2008 which Enzon could easily tap to implement a share repurchase program, particularly in light of the Company’s undervaluation. Indeed, every share that is bought at a discount to intrinsic value makes every remaining share worth more; at current prices, Enzon could repurchase more than half of its outstanding shares with just this existing cash!”—Since writing this letter in October 6th, shares of Enzon have fallen an additional 25% An additional positive going forward is that Enzon’s Oncaspar-IV cancer druge has received orphan drug status in the EU. Enzon said “Oncaspar-IV is a treatment for acute lymphoblastic leukemia, the most common type of cancer in children. The Commission of the European Communities awarded the drug orphan medicinal product status, which will block rival versions of the drug from the market for 10 years if regulators approve Oncaspar-IV for sale. Oncaspar is designed to kill cancer cells by starving them of an essential amino acid”—while this is not a game changer, there have been rumors that the company might sell this off to a larger European based drug marker. Important takeaway: 1) shares of Enzon are extremely beaten down; despite any real change in Enzon’s business, sales and revenue 2) Activist investors who have large financial stakes in Enzon are pushing the company to break themselves up

People owning ENZN also tend to own: BEASELOSGMNBIXPHRMQIDBGG

TheStreet.com Rating: C What is this?

  • +
  • FWLT
    Foster Wheeler Ag
  • $32.00
  • -1.99%
  • $32.16

No Analysis added

People owning FWLT also tend to own: ABKBBDCFCDEFCXFREHES

TheStreet.com Rating: C+ What is this?

  • +
  • FST
    Forest Oil Cp (ne
  • $17.68
  • -3.07%
  • $18.04

No Analysis added

People owning FST also tend to own: ACAAPACALMGLDDNBGNXYSYNX

TheStreet.com Rating: D What is this?

  • +
  • PQ
    Petroquest Energy
  • $5.84
  • -1.02%
  • $5.86

No Analysis added

People owning PQ also tend to own: DGOOGHALMSFTSHLDTASRADELQ.PK

TheStreet.com Rating: D What is this?

  • +
  • MT
    Arcelor Mittal Ne
  • $37.88
  • +0.19%
  • $37.64

No Analysis added

People owning MT also tend to own: CXFCXFTEKNMXNYXRIOTM

TheStreet.com Rating: No Rating What is this?

  • +
  • CCI
    Crown Castle Intl
  • $37.45
  • +1.24%
  • $36.74

No Analysis added

People owning CCI also tend to own: BGFELPFRGLNOPOPSWPGHSSRI

TheStreet.com Rating: D+ What is this?

  • +
  • XTO
    Xto Energy Inc
  • $41.11
  • -1.25%
  • $41.35

No Analysis added

People owning XTO also tend to own: APAAPCBHICHKCOPCVXDVN

TheStreet.com Rating: B What is this?

  • +
  • HNZ
    Heinz H J Co
  • $42.23
  • +0.52%
  • $41.87

Big yeild

People owning HNZ also tend to own: DENNDRTEIASGJRCCMCDNOOFPBY

TheStreet.com Rating: B+ What is this?

previous next

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Cramer's Take on Headline Stocks...

Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...

11.20.09 | 11:48 AM
Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...

11.20.09 | 08:09 AM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...

11.19.09 | 11:13 AM
Squeezing the Shorts: Earnings G...

By Jonas Elmerraji Posted on Nov. 18, 2009 There are plenty of reasons for stocks to have the attention of short-sellers. Waning financials, a deteriorating business mo...

11.18.09 | 12:36 PM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
48 years old, IN debt, college w...
11.21.09 | 07:51 AM From author schmls
Gloomy Bear Blood Dripping Corner
02.02.09 | 09:25 AM From author Madeleine
more forums
Q. Stockpickrs, I want to invest in...
11.22.09 | 14:33 PM Asked by reinorht

A. part of the circle of friends.

FFH

today 's lists
52-Week Lows

Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 20, 2009. more

TheStreet.com TV Videos

These are some of the stocks mentioned on TheStreet.com TV recently. Click the URL below each stock to watch the videos. more

Biggest % Gainers

Here are some of the largest % gainers from Nov. 20, 2009. more